![Li Zeng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Li Zeng
Direttore/Membro del Consiglio presso
EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED
Profilo
Li Zeng currently works at Extrawell Pharmaceutical Holdings Ltd., as Independent Non-Executive Director from 2024 and CytoCares Shanghai, Inc., as Chief Operating Officer.
Dr. Zeng received his undergraduate degree in 2000 from Fudan University and doctorate degree in 2005 from Fudan University.
Posizioni attive di Li Zeng
| Società | Posizione | Inizio |
|---|---|---|
| EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED | Direttore/Membro del Consiglio | 07/06/2024 |
CytoCares Shanghai, Inc.
 CytoCares Shanghai, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative multispecific antibody drugs for oncology and autoimmune diseases | Direttore operativo | - |
Formazione di Li Zeng
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Extrawell Pharmaceutical Holdings Ltd.
 Extrawell Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoCares Shanghai, Inc.
CytoCares Shanghai, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative multispecific antibody drugs for oncology and autoimmune diseases | Health Technology |
